SPASOJE NESKOVIC: Open Payments
NPI 1780792739 · BURBANK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 14 payments from 7 companies in 2025. Trend: 2023 $99 · 2024 $450 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $191 |
| ABBVIE INC. | 2 | $149 |
| Kowa Pharmaceuticals America, Inc. | 2 | $37 |
| Amgen Inc. | 2 | $35 |
| GlaxoSmithKline, LLC. | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $14 |
Products named: XIFAXAN, UBRELVY, ZORYVE, REPATHA, TRELEGY ELLIPTA, JARDIANCE, QULIPTA, MOUNJARO.
Industry payments across CA — which companies pay providers there.
